High-flow nasal cannula oxygen therapy for the treatment of acute respiratory failure secondary to SARS-CoV-2 pneumonia out of ICU.

Sonia CastroSandra PedreroLuis Alberto RuizLeyre SerranoRafael ZalacainSilvia Pérez-FernándezMilagros IriberriValentín Cabriada Nuño

Published in: The clinical respiratory journal (2023)

HFNC outside an ICU is a treatment with high success rate in patients with AHRF secondary to SARS-CoV-2 pneumonia, including in patients in whom this therapy was deemed to be the ceiling of treatment.

Keyphrases

respiratory failure
sars cov
mechanical ventilation
extracorporeal membrane oxygenation
intensive care unit
end stage renal disease
chronic kidney disease
stem cells
newly diagnosed
obstructive sleep apnea
combination therapy
bone marrow
hepatitis b virus
prognostic factors